Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Hydrocortisone Acetate Suppository vs Cortenema in Healthy Subjects
NCT02671058Phase 1Completed
- Sponsor
- Cristcot
- Start
- Mar 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of hydrocortisone in ulcerative colitis (UC) (2 arms), sponsored by Cristcot. Primary endpoint: primary PK endpoints at 24 hours. Started Mar 2016; status: completed.
02
Drugs
hydrocortisone
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02671058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02671058.